Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 286,342 | 13,971 | 13,046 | 37,700 | 9,913 |
| Operating Income | -286,342 | -13,971 | -13,046 | -37,700 | -9,913 |
| Other Income | -39,030 | -1,408 | -4,593 | -9,076 | -525 |
| Pre-tax Income | -325,372 | -15,379 | -17,639 | -46,776 | -10,438 |
| Net Income Continuous | -325,372 | -15,379 | -17,639 | -46,759 | -10,438 |
| Net Income | $-325,372 | $-15,379 | $-17,639 | $-46,759 | $-10,438 |
| EPS Basic Total Ops | -630.22 | -7.91 | -9.35 | -30.94 | -5.76 |
| EPS Basic Continuous Ops | -629.93 | -7.97 | -9.14 | -70.21 | -5.41 |
| EPS Diluted Total Ops | -630.22 | -7.91 | -9.35 | -30.94 | -5.76 |
| EPS Diluted Continuous Ops | -629.93 | -7.97 | -9.14 | -70.21 | -5.41 |
| EBITDA(a) | $-286,315 | $-13,948 | $-13,021 | $-37,668 | $-9,913 |